186 related articles for article (PubMed ID: 32941398)
21. Effectiveness of lacosamide in children and young adults previously treated with other sodium channel blockers.
Suzuki T; Natsume J; Kumai S; Maki Y; Yamamoto H; Numoto S; Narahara S; Kubota T; Tsuji T; Kato T; Yamada K; Maruyama K; Okumura A; Takahashi Y; Kidokoro H
Epilepsy Behav; 2021 Dec; 125():108397. PubMed ID: 34814035
[TBL] [Abstract][Full Text] [Related]
22. Lacosamide effectiveness and tolerability in patients with drug-resistant epilepsy and severe disability under polytherapy: Therapy optimization as emerging from an observational study.
Pozzi M; Zanotta N; Epifanio R; Baldelli S; Cattaneo D; Clementi E; Zucca C
Epilepsy Behav; 2022 Mar; 128():108598. PubMed ID: 35151192
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs.
Vohora D; Saraogi P; Yazdani MA; Bhowmik M; Khanam R; Pillai KK
Drugs Today (Barc); 2010 Apr; 46(4):265-77. PubMed ID: 20502724
[TBL] [Abstract][Full Text] [Related]
24. Novel medications for epilepsy.
Fattore C; Perucca E
Drugs; 2011 Nov; 71(16):2151-78. PubMed ID: 22035515
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
26. The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting.
Sanmartí-Vilaplana F; Díaz-Gómez A
Epilepsy Behav; 2018 Feb; 79():130-137. PubMed ID: 29287216
[TBL] [Abstract][Full Text] [Related]
27. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Contin M; Riva R; Albani F; Avoni P; Baruzzi A
Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
[TBL] [Abstract][Full Text] [Related]
28. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
[TBL] [Abstract][Full Text] [Related]
29. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
[TBL] [Abstract][Full Text] [Related]
31. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.
Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J
Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice.
Verrotti A; Lattanzi S; Brigo F; Zaccara G
Epilepsy Behav; 2020 Mar; 104(Pt A):106939. PubMed ID: 32058303
[TBL] [Abstract][Full Text] [Related]
33. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H
Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic intervention and treatment of childhood seizure disorders: relative efficacy and safety of antiepileptic drugs.
Bourgeois BF
Epilepsia; 1994; 35 Suppl 2():S18-23. PubMed ID: 8275977
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Drug Monitoring for Rufinamide in Japanese Patients With Epilepsy: Focus on Drug Interactions, Tolerability, and Clinical Effectiveness.
Yamamoto Y; Inoue Y; Usui N; Imai K; Kagawa Y; Takahashi Y
Ther Drug Monit; 2022 Aug; 44(4):585-591. PubMed ID: 35213526
[TBL] [Abstract][Full Text] [Related]
36. Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort.
McGinnis E; Kessler SK
Epilepsia; 2016 Sep; 57(9):1416-25. PubMed ID: 27430392
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
[TBL] [Abstract][Full Text] [Related]
38. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
[TBL] [Abstract][Full Text] [Related]
40. [Clinical experience with lacosamide in Galicia: the GALACO study].
Rodriguez-Osorio X; Lopez-Gonzalez FJ; Pato-Pato A; Cebrian-Perez E; Marey-Lopez J; Corredera-Garcia E; Rubio-Nazabal E; Castro-Vilanova MD; Abella-Corral J; Rodriguez-Regal A; Amigo-Jorrin MC; Pego-Reigosa R;
Rev Neurol; 2015 Dec; 61(12):536-42. PubMed ID: 26662871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]